FlowView joins the EU RESOLVE project!
8 million EU-funding: “Flowview Diagnostics BV” successful with research consortium RESOLVE, which will define the golden standard in AML and CLL treatment using personalized diagnostics. What is the RESOLVE Project? The RESOLVE project is a groundbreaking EU-funded program with the objective at standardizing measurable residual disease (MRD) diagnostics for better treatment of blood cancers, especially […]
